0001628280-20-014320.txt : 20201006
0001628280-20-014320.hdr.sgml : 20201006
20201006073632
ACCESSION NUMBER: 0001628280-20-014320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201005
FILED AS OF DATE: 20201006
DATE AS OF CHANGE: 20201006
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bridger Gary
CENTRAL INDEX KEY: 0001600049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 201225578
MAIL ADDRESS:
STREET 1: C/O FIVE CORNERS CAPITAL
STREET 2: 700 WEST GEORGIA STREET, SUITE 2500
CITY: VANCOUVER
STATE: A1
ZIP: V7Y 1B3
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
BUSINESS PHONE: 857-529-8300
MAIL ADDRESS:
STREET 1: 61 NORTH BEACON STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02134
FORMER COMPANY:
FORMER CONFORMED NAME: Arsanis, Inc.
DATE OF NAME CHANGE: 20100920
4
1
wf-form4_160198417729837.xml
FORM 4
X0306
4
2020-10-05
0
0001501697
X4 Pharmaceuticals, Inc
XFOR
0001600049
Bridger Gary
C/O X4 PHARMACEUTICALS, INC.
61 NORTH BEACON STREET, 4TH FLOOR
BOSTON
MA
02134
1
0
0
0
Stock Option (right to buy)
7.33
2020-10-05
4
A
0
30000
0
A
2030-10-04
Common Stock
30000.0
30000
D
33.3333% of the shares subject to the option shall vest on October 5, 2021, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.
Derek M. Meisner, attorney-in-fact
2020-10-06